ADVANCE-2: Addressing Dementia Via Agitation-Centered Evaluation: A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-05 for the Treatment of Alzheimer’s Disease Agitation
Purpose
Category
IRB Number
20220495HU
NCT Number
-
Open to Enrollment
Yes
Sponsor
-
Study Contact
Principal Investigator
Neela Patel
Floyd Jones
+1 (210) 450-3158
jonesfa@uthscsa.edu
Eligibility
Eligible Ages
Eligible Genders
Accepts Healthy Volunteers
No
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups